Medtech.
Advancing healthcare through technology.
We turn complex challenges into life-changing medical technologies – combining deep expertise in embedded systems, signal processing, AI, and user-centred design. As a full-solution partner, we take ideas from concept to certified, production-ready innovations that improve lives.
Experience.
Full-solution partner
Qamcom delivers medtech projects from idea through concept to products for serial production.
Broad and deep expertise
Combining embedded systems, signal processing, AI, and systems development for medtech applications.
Trusted by industry leaders
Recognized as a reliable partner, delivering high-quality solutions for healthcare and life sciences.
Complete competence
Expertise in HW, FW, SW, algorithms, certification and user interface design – all under one roof.
Capabilities.
Broad and deep expertise
Multidisciplinary team driving innovation from concept to final product.
Industrial AI
Enhancing medical analysis tools with expertise in signal processing and Machine Learning.
Hardware & firmware development
Precision devices for healthcare.
Embedded sensor systems
Real-time systems tailored for medtech.
Software & algorithms
Advanced analysis, automation, signal processing and AI.
Testing & validation
Ensuring compliance and performance.
Medtech client and case studies.
- Mabtech
- Ortoma
- RTHS
Mabtech EYRA – multiplex platform for vaccine and treatment development
Mabtech and Qamcom have collaborated on R&D since 2016, with the Iris and Astor platforms among the joint innovations. The EYRA platform marks a new chapter — a no-contact, automation-ready instrument built around a purpose-built confocal microscope, designed to redefine what's possible in multiplex analysis.
Making vaccine research more efficient and accurate.
Mabtech is a Swedish biotech company specialising in immunoassays for research and clinical diagnostics. Their FluoroSpot, ELISpot, and FociSpot readers are used worldwide in vaccine development and disease characterisation — and making them more accurate and easier to use directly translates to faster research outcomes.
3D imaging into more accurate surgeries
Hip surgery is one of the most common procedures in the world, yet most surgeons still rely on 2D X-rays for planning. Ortoma set out to change that with an AI-powered 3D imaging platform built on CT data — and turned to Qamcom for the software foundation.
Mabtech and Qamcom reinvent spot analysis with Mabtech Iris™
Mabtech is a Swedish biotech company. Founded by researchers in 1986, the Stockholm-based company is still run by researchers today and is internationally renowned for the tools it has developed for life science research, in particular in the field of immunology.
Mabtech is a leader in providing monoclonal antibodies and kits suitable for ELISpot and FluoroSpot analysis. Used by scientists worldwide to study immune responses in, for example, infectious diseases, cancers, allergies, transplantations and vaccine trials, the kits required third party readers for spot analysis. These readers lack the accuracy and precision needed in analysing spots secreted by single immune cells. Furthermore, they require calibration by the user – a step which will invariably add an element of subjectivity to the analysis and might therefore compromise the accuracy of the results.
Passionate about biomedical research and ensuring extreme accuracy in the discovery process, the Mabtech team felt that the situation could be improved.
"In order to realise our goal of fundamentally redefining spot reading technology, we needed a partner who could not only bring the technical skills we required, but who would also truly share our passion for the project. Qamcom did both, overcoming significant development challenges and delivering some brilliant enhancements to the product that even we had not thought of. Working with Qamcom, we were confident that there were no boundaries to what we could achieve together."
Christian Smedman, CTO, Mabtech
Contact us.
